| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enzyme Inhibitors | 13 | 2022 | 581 | 3.120 |
Why?
|
| Histones | 12 | 2022 | 525 | 2.280 |
Why?
|
| Methyltransferases | 8 | 2016 | 71 | 2.080 |
Why?
|
| Leukemia, Myeloid, Acute | 6 | 2022 | 536 | 1.670 |
Why?
|
| Antineoplastic Agents | 8 | 2021 | 1694 | 1.560 |
Why?
|
| Histone Demethylases | 3 | 2017 | 39 | 1.520 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2021 | 210 | 1.310 |
Why?
|
| Structure-Activity Relationship | 12 | 2022 | 581 | 1.270 |
Why?
|
| Lysine | 5 | 2022 | 196 | 1.180 |
Why?
|
| Aldose-Ketose Isomerases | 3 | 2013 | 11 | 1.110 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2018 | 74 | 1.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 8 | 2021 | 156 | 1.070 |
Why?
|
| Antiviral Agents | 5 | 2025 | 753 | 1.070 |
Why?
|
| Leukemia | 2 | 2021 | 372 | 0.980 |
Why?
|
| Pyrazines | 2 | 2022 | 75 | 0.890 |
Why?
|
| Acetamides | 1 | 2024 | 47 | 0.850 |
Why?
|
| Proteolysis | 2 | 2022 | 171 | 0.810 |
Why?
|
| Monoamine Oxidase Inhibitors | 3 | 2017 | 11 | 0.810 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2022 | 65 | 0.780 |
Why?
|
| Neoplasms | 4 | 2022 | 2794 | 0.750 |
Why?
|
| Protein Interaction Maps | 1 | 2021 | 78 | 0.710 |
Why?
|
| Molecular Structure | 6 | 2021 | 295 | 0.700 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2021 | 36 | 0.700 |
Why?
|
| Wilms Tumor | 1 | 2022 | 115 | 0.700 |
Why?
|
| Oxidoreductases | 2 | 2011 | 92 | 0.680 |
Why?
|
| Multienzyme Complexes | 2 | 2011 | 89 | 0.680 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 180 | 0.670 |
Why?
|
| Viral Proteins | 2 | 2021 | 347 | 0.670 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2019 | 39 | 0.620 |
Why?
|
| DNA Methylation | 2 | 2016 | 1007 | 0.620 |
Why?
|
| Zika Virus Infection | 1 | 2021 | 171 | 0.610 |
Why?
|
| Pyridines | 2 | 2020 | 230 | 0.600 |
Why?
|
| Norovirus | 4 | 2025 | 317 | 0.600 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2018 | 78 | 0.580 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2018 | 86 | 0.580 |
Why?
|
| Cell Line, Tumor | 9 | 2021 | 3348 | 0.570 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 438 | 0.570 |
Why?
|
| Crystallography, X-Ray | 7 | 2024 | 357 | 0.560 |
Why?
|
| Gene Rearrangement | 2 | 2016 | 320 | 0.540 |
Why?
|
| Cell Proliferation | 9 | 2020 | 2312 | 0.540 |
Why?
|
| Virus Replication | 4 | 2025 | 607 | 0.530 |
Why?
|
| Adenosine | 3 | 2016 | 127 | 0.510 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 358 | 0.500 |
Why?
|
| Thiohydantoins | 1 | 2015 | 3 | 0.500 |
Why?
|
| Peptide Hydrolases | 4 | 2023 | 145 | 0.500 |
Why?
|
| Glucocorticoids | 1 | 2018 | 382 | 0.480 |
Why?
|
| Models, Molecular | 7 | 2021 | 1079 | 0.460 |
Why?
|
| Drug Discovery | 3 | 2023 | 171 | 0.460 |
Why?
|
| Piperidines | 1 | 2015 | 208 | 0.450 |
Why?
|
| Pyridones | 3 | 2014 | 118 | 0.430 |
Why?
|
| Anti-Bacterial Agents | 4 | 2019 | 2430 | 0.420 |
Why?
|
| Transcriptional Elongation Factors | 3 | 2022 | 25 | 0.420 |
Why?
|
| Methylation | 5 | 2016 | 221 | 0.410 |
Why?
|
| Toxoplasma | 1 | 2013 | 15 | 0.410 |
Why?
|
| Carboxylic Acids | 1 | 2012 | 25 | 0.400 |
Why?
|
| Humans | 34 | 2025 | 125195 | 0.390 |
Why?
|
| Thiazoles | 1 | 2012 | 98 | 0.380 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2012 | 60 | 0.380 |
Why?
|
| Caliciviridae Infections | 4 | 2025 | 328 | 0.370 |
Why?
|
| Protease Inhibitors | 3 | 2025 | 96 | 0.370 |
Why?
|
| Organophosphonates | 1 | 2011 | 20 | 0.370 |
Why?
|
| Animals | 17 | 2023 | 34238 | 0.350 |
Why?
|
| Gastroenteritis | 3 | 2025 | 349 | 0.340 |
Why?
|
| Protein Conformation | 5 | 2021 | 834 | 0.330 |
Why?
|
| Breast Neoplasms | 4 | 2020 | 2512 | 0.330 |
Why?
|
| Kinetics | 3 | 2017 | 1332 | 0.330 |
Why?
|
| Chelating Agents | 1 | 2009 | 42 | 0.330 |
Why?
|
| Neoplastic Stem Cells | 3 | 2018 | 293 | 0.330 |
Why?
|
| Magnesium | 1 | 2009 | 123 | 0.320 |
Why?
|
| Escherichia coli | 4 | 2019 | 985 | 0.310 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2016 | 94 | 0.310 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2018 | 63 | 0.300 |
Why?
|
| Cell Differentiation | 5 | 2020 | 1898 | 0.290 |
Why?
|
| Thermodynamics | 2 | 2019 | 144 | 0.270 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2016 | 889 | 0.270 |
Why?
|
| DNA-Binding Proteins | 3 | 2023 | 2048 | 0.270 |
Why?
|
| Apoptosis | 5 | 2018 | 1806 | 0.270 |
Why?
|
| Gene Expression | 2 | 2022 | 1561 | 0.270 |
Why?
|
| Molecular Docking Simulation | 3 | 2023 | 110 | 0.270 |
Why?
|
| Mice | 10 | 2022 | 17637 | 0.260 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2020 | 358 | 0.260 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 286 | 0.260 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 362 | 0.250 |
Why?
|
| Mice, SCID | 2 | 2018 | 569 | 0.250 |
Why?
|
| Mutation | 6 | 2019 | 5842 | 0.240 |
Why?
|
| Acetylation | 2 | 2022 | 166 | 0.230 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 140 | 0.220 |
Why?
|
| Epoxy Compounds | 1 | 2024 | 18 | 0.220 |
Why?
|
| Estrogen Receptor alpha | 2 | 2020 | 458 | 0.220 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2023 | 30 | 0.210 |
Why?
|
| Viral Vaccines | 2 | 2025 | 337 | 0.210 |
Why?
|
| DNA | 2 | 2019 | 1608 | 0.210 |
Why?
|
| Blotting, Western | 2 | 2016 | 1102 | 0.210 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 253 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 1290 | 0.200 |
Why?
|
| Acetyltransferases | 1 | 2022 | 90 | 0.190 |
Why?
|
| Histone Acetyltransferases | 1 | 2022 | 314 | 0.180 |
Why?
|
| Allosteric Regulation | 1 | 2021 | 48 | 0.180 |
Why?
|
| Cyclohexanones | 1 | 2020 | 17 | 0.180 |
Why?
|
| Protein Binding | 3 | 2015 | 1757 | 0.170 |
Why?
|
| Oncogenes | 1 | 2021 | 167 | 0.170 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2020 | 14 | 0.170 |
Why?
|
| Dengue Virus | 1 | 2021 | 127 | 0.170 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 184 | 0.160 |
Why?
|
| MCF-7 Cells | 2 | 2020 | 222 | 0.160 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2019 | 1 | 0.160 |
Why?
|
| Ubiquitination | 1 | 2020 | 167 | 0.160 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2021 | 191 | 0.160 |
Why?
|
| West Nile virus | 1 | 2021 | 117 | 0.160 |
Why?
|
| Calorimetry | 1 | 2019 | 62 | 0.160 |
Why?
|
| Receptors, Steroid | 1 | 2020 | 274 | 0.160 |
Why?
|
| Zika Virus | 1 | 2021 | 144 | 0.160 |
Why?
|
| Carcinogenesis | 1 | 2022 | 333 | 0.160 |
Why?
|
| Sugars | 1 | 2019 | 15 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1101 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1696 | 0.150 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2013 | 365 | 0.150 |
Why?
|
| Ligands | 1 | 2020 | 539 | 0.150 |
Why?
|
| Iron | 2 | 2019 | 270 | 0.150 |
Why?
|
| Glutarates | 2 | 2015 | 37 | 0.150 |
Why?
|
| Substrate Specificity | 2 | 2015 | 295 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2019 | 541 | 0.140 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 121 | 0.140 |
Why?
|
| Acinetobacter baumannii | 2 | 2019 | 37 | 0.140 |
Why?
|
| Hematopoiesis | 1 | 2019 | 216 | 0.140 |
Why?
|
| Monoamine Oxidase | 1 | 2017 | 11 | 0.140 |
Why?
|
| Cyclopropanes | 1 | 2017 | 68 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 256 | 0.130 |
Why?
|
| Mice, Nude | 2 | 2016 | 708 | 0.130 |
Why?
|
| Naphthols | 1 | 2016 | 7 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2018 | 279 | 0.130 |
Why?
|
| U937 Cells | 1 | 2016 | 25 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 2 | 2014 | 1064 | 0.130 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 1266 | 0.130 |
Why?
|
| Drug Synergism | 1 | 2016 | 229 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 213 | 0.120 |
Why?
|
| Cell Survival | 1 | 2018 | 813 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2014 | 618 | 0.120 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2019 | 797 | 0.120 |
Why?
|
| Carrier Proteins | 2 | 2023 | 1021 | 0.120 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 138 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 258 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2016 | 271 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 221 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 50 | 0.110 |
Why?
|
| Drug Repositioning | 1 | 2013 | 23 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 1050 | 0.100 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2012 | 7 | 0.100 |
Why?
|
| Klebsiella pneumoniae | 1 | 2013 | 76 | 0.100 |
Why?
|
| Catalytic Domain | 2 | 2025 | 158 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 506 | 0.100 |
Why?
|
| Tamoxifen | 1 | 2014 | 363 | 0.100 |
Why?
|
| Plasmodium falciparum | 1 | 2013 | 64 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2014 | 797 | 0.100 |
Why?
|
| Disease | 1 | 2013 | 129 | 0.100 |
Why?
|
| Norwalk virus | 1 | 2013 | 170 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 77 | 0.090 |
Why?
|
| Transcriptome | 1 | 2018 | 954 | 0.090 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2011 | 15 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2019 | 2593 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 152 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 503 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 678 | 0.090 |
Why?
|
| Cell Movement | 1 | 2014 | 847 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 668 | 0.090 |
Why?
|
| beta-Lactamases | 1 | 2012 | 198 | 0.080 |
Why?
|
| Fosfomycin | 1 | 2009 | 2 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 725 | 0.080 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 74 | 0.080 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2009 | 42 | 0.080 |
Why?
|
| Gram-Positive Bacteria | 1 | 2009 | 47 | 0.080 |
Why?
|
| Gram-Negative Bacteria | 1 | 2009 | 68 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2014 | 813 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1398 | 0.080 |
Why?
|
| Antitubercular Agents | 1 | 2011 | 250 | 0.080 |
Why?
|
| Mitosis | 1 | 2009 | 237 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2821 | 0.070 |
Why?
|
| Cell Line | 2 | 2009 | 2758 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2011 | 383 | 0.070 |
Why?
|
| Galactose | 2 | 2019 | 54 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2023 | 723 | 0.060 |
Why?
|
| Crystallography | 1 | 2025 | 40 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2025 | 106 | 0.060 |
Why?
|
| Binding Sites | 2 | 2021 | 1304 | 0.050 |
Why?
|
| Polyproteins | 1 | 2021 | 8 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 39 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2020 | 57 | 0.040 |
Why?
|
| Transcription Factor AP-2 | 1 | 2020 | 22 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 1893 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 100 | 0.040 |
Why?
|
| Enterobactin | 1 | 2019 | 2 | 0.040 |
Why?
|
| Klebsiella | 1 | 2019 | 9 | 0.040 |
Why?
|
| Siderophores | 1 | 2019 | 10 | 0.040 |
Why?
|
| Female | 5 | 2020 | 66803 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 436 | 0.040 |
Why?
|
| Child | 2 | 2016 | 24407 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2019 | 211 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 735 | 0.040 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 133 | 0.040 |
Why?
|
| RNA | 1 | 2020 | 570 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 625 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2016 | 33 | 0.030 |
Why?
|
| Virus Attachment | 1 | 2016 | 41 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2019 | 290 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 55 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2020 | 888 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2016 | 48 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 49 | 0.030 |
Why?
|
| Genotype | 1 | 2021 | 2564 | 0.030 |
Why?
|
| Interferons | 1 | 2016 | 125 | 0.030 |
Why?
|
| Capsid Proteins | 1 | 2016 | 184 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2016 | 140 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1700 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2020 | 4536 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2014 | 35 | 0.030 |
Why?
|
| Antibodies | 1 | 2016 | 374 | 0.030 |
Why?
|
| E2F1 Transcription Factor | 1 | 2014 | 48 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2014 | 32 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 173 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 376 | 0.030 |
Why?
|
| Azepines | 1 | 2014 | 63 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 142 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 25 | 0.030 |
Why?
|
| Triazoles | 1 | 2014 | 138 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2013 | 42 | 0.030 |
Why?
|
| Epigenomics | 1 | 2014 | 164 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1448 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2013 | 66 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 2013 | 194 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 112 | 0.030 |
Why?
|
| Estradiol | 1 | 2014 | 532 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 296 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 548 | 0.020 |
Why?
|
| DNA Damage | 1 | 2014 | 513 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2013 | 304 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 573 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 657 | 0.020 |
Why?
|
| S-Adenosylmethionine | 1 | 2009 | 29 | 0.020 |
Why?
|
| Glioma | 1 | 2014 | 492 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2009 | 79 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2009 | 45 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 3727 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 368 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 767 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4405 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 6336 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 1631 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 1216 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 4263 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 12507 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 14022 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 19355 | 0.010 |
Why?
|
| Male | 1 | 2014 | 61524 | 0.000 |
Why?
|